GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Minority Interest

RDTCF (Rapid Dose Therapeutics) Minority Interest : $0.00 Mil (As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Rapid Dose Therapeutics's minority interest for the quarter that ended in Aug. 2024 was $0.00 Mil.


Rapid Dose Therapeutics Minority Interest Historical Data

The historical data trend for Rapid Dose Therapeutics's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Minority Interest Chart

Rapid Dose Therapeutics Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rapid Dose Therapeutics Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rapid Dose Therapeutics Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Rapid Dose Therapeutics Business Description

Traded in Other Exchanges
Address
1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Rapid Dose Therapeutics Headlines

From GuruFocus

Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update

By Business Wire Business Wire 08-25-2022

Rapid Dose Therapeutics Corp Announces Proposed Private Placement

By Business Wire Business Wire 05-26-2022

Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial Results

By Business Wire Business Wire 02-01-2023

Rapid Dose Announces Revocation of Cease Trade Order

By Business Wire Business Wire 05-02-2023

Rapid Dose Announces Filing of Corrective Disclosure

By Business Wire Business Wire 04-14-2023